ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 165 filers reported holding ANIKA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,212 | +126.8% | 3,393 | +216.2% | 0.00% | – |
| Q2 2023 | $27,877 | -9.5% | 1,073 | 0.0% | 0.00% | – |
| Q1 2023 | $30,817 | -3.0% | 1,073 | 0.0% | 0.00% | – |
| Q4 2022 | $31,761 | +22.2% | 1,073 | 0.0% | 0.00% | – |
| Q3 2022 | $26,000 | +8.3% | 1,073 | 0.0% | 0.00% | – |
| Q2 2022 | $24,000 | -11.1% | 1,073 | 0.0% | 0.00% | – |
| Q1 2022 | $27,000 | -28.9% | 1,073 | 0.0% | 0.00% | – |
| Q4 2021 | $38,000 | -17.4% | 1,073 | 0.0% | 0.00% | – |
| Q3 2021 | $46,000 | 0.0% | 1,073 | 0.0% | 0.00% | – |
| Q2 2021 | $46,000 | +4.5% | 1,073 | 0.0% | 0.00% | – |
| Q1 2021 | $44,000 | -10.2% | 1,073 | 0.0% | 0.00% | – |
| Q4 2020 | $49,000 | -29.0% | 1,073 | -44.7% | 0.00% | – |
| Q3 2020 | $69,000 | -5.5% | 1,939 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $73,000 | +160.7% | 1,939 | +102.6% | 0.00% | – |
| Q1 2020 | $28,000 | -44.0% | 957 | 0.0% | 0.00% | – |
| Q4 2019 | $50,000 | -5.7% | 957 | 0.0% | 0.00% | – |
| Q3 2019 | $53,000 | +35.9% | 957 | 0.0% | 0.00% | – |
| Q2 2019 | $39,000 | +34.5% | 957 | 0.0% | 0.00% | – |
| Q1 2019 | $29,000 | -9.4% | 957 | 0.0% | 0.00% | – |
| Q4 2018 | $32,000 | -20.0% | 957 | 0.0% | 0.00% | – |
| Q3 2018 | $40,000 | +29.0% | 957 | 0.0% | 0.00% | – |
| Q2 2018 | $31,000 | -35.4% | 957 | 0.0% | 0.00% | – |
| Q1 2018 | $48,000 | -7.7% | 957 | 0.0% | 0.00% | – |
| Q4 2017 | $52,000 | +57.6% | 957 | +66.7% | 0.00% | – |
| Q3 2017 | $33,000 | +17.9% | 574 | 0.0% | 0.00% | – |
| Q2 2017 | $28,000 | +12.0% | 574 | 0.0% | 0.00% | – |
| Q1 2017 | $25,000 | -10.7% | 574 | 0.0% | 0.00% | – |
| Q4 2016 | $28,000 | +3.7% | 574 | 0.0% | 0.00% | – |
| Q3 2016 | $27,000 | +12.5% | 574 | +28.1% | 0.00% | – |
| Q2 2016 | $24,000 | +20.0% | 448 | 0.0% | 0.00% | – |
| Q1 2016 | $20,000 | +17.6% | 448 | 0.0% | 0.00% | – |
| Q4 2015 | $17,000 | +183.3% | 448 | +128.6% | 0.00% | – |
| Q3 2015 | $6,000 | 0.0% | 196 | 0.0% | 0.00% | – |
| Q2 2015 | $6,000 | -25.0% | 196 | 0.0% | 0.00% | – |
| Q1 2015 | $8,000 | – | 196 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
| CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
| AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
| Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
| Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
| Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
| DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
| THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
| NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
| Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |